- Report
- September 2024
- 225 Pages
Global
From €1689EUR$1,859USD£1,446GBP
€2413EUR$2,655USD£2,066GBP
- Report
- April 2024
- 275 Pages
Global
From €2271EUR$2,499USD£1,945GBP
€3245EUR$3,570USD£2,778GBP
- Report
- October 2023
- 272 Pages
Global
From €2271EUR$2,499USD£1,945GBP
€3245EUR$3,570USD£2,778GBP
- Report
- March 2022
- 210 Pages
Global
From €2271EUR$2,499USD£1,945GBP
€3245EUR$3,570USD£2,778GBP
- Report
- March 2022
- 230 Pages
Global
From €2199EUR$2,419USD£1,883GBP
€3141EUR$3,456USD£2,690GBP
- Report
- March 2022
- 256 Pages
Global
From €2268EUR$2,496USD£1,942GBP
€3240EUR$3,565USD£2,775GBP
- Report
- December 2021
- 257 Pages
Global
From €2362EUR$2,598USD£2,022GBP
€3374EUR$3,712USD£2,889GBP
- Book
- August 2023
Global
- Book
- May 2025
- 384 Pages
- Book
- January 2024
- 400 Pages
- Book
- November 2011
- 496 Pages
Global
- Book
- September 2009
- 400 Pages
- Book
- November 2018
- 326 Pages
- Book
- April 2013
- 632 Pages
- Book
- June 2010
- 471 Pages
- Book
- January 2025
Global

Molecular Diagnostics is a type of medical testing that uses molecular biology techniques to detect and diagnose diseases. It is used to identify genetic mutations, diagnose infectious diseases, and detect cancer. Molecular Diagnostics can also be used to monitor the effectiveness of treatments.
Molecular Diagnostics is used in a variety of settings, including hospitals, laboratories, and research facilities. It is used to diagnose a wide range of conditions, including cancer, infectious diseases, genetic disorders, and inherited diseases. Molecular Diagnostics can also be used to detect the presence of certain viruses and bacteria.
Some of the companies in the Molecular Diagnostics market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Cepheid, and Qiagen. These companies provide a range of products and services, including diagnostic tests, reagents, and instruments. Show Less Read more